IDXX
Price
$435.69
Change
-$2.96 (-0.67%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call
XRAY
Price
$33.88
Change
-$0.28 (-0.82%)
Updated
Sep 22, 6:59 PM EST
41 days until earnings call

Analysis and predictions IDXX vs XRAY

Header iconIDXX vs XRAY Comparison
Open Charts IDXX vs XRAYBanner chart's image
IDEXX Laboratories
Price$435.69
Change-$2.96 (-0.67%)
Volume$241.06K
CapitalizationN/A
DENTSPLY SIRONA
Price$33.88
Change-$0.28 (-0.82%)
Volume$829.67K
CapitalizationN/A
View a ticker or compare two or three
IDXX vs XRAY Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
IDXX vs. XRAY commentary
Sep 23, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a StrongSell and XRAY is a Hold.

COMPARISON
Comparison
Sep 23, 2023
Stock price -- (IDXX: $435.69 vs. XRAY: $33.88)
Brand notoriety: IDXX and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 100% vs. XRAY: 215%
Market capitalization -- IDXX: $36.41B vs. XRAY: $7.23B
IDXX [@Medical Specialties] is valued at $36.41B. XRAY’s [@Medical Specialties] market capitalization is $7.23B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 4 bullish, 6 bearish.
  • XRAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than IDXX.

Price Growth

IDXX (@Medical Specialties) experienced а -3.33% price change this week, while XRAY (@Medical Specialties) price change was -4.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.81%. For the same industry, the average monthly price growth was -6.58%, and the average quarterly price growth was -7.33%.

Reported Earning Dates

IDXX is expected to report earnings on Oct 31, 2023.

XRAY is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Medical Specialties (-3.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for IDXX with price predictions.
OPEN
A.I.dvisor published
a Summary for XRAY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IDXX($36.4B) has a higher market cap than XRAY($7.23B). IDXX has higher P/E ratio than XRAY: IDXX (46.51) vs XRAY (19.23). XRAY YTD gains are higher at: 8.068 vs. IDXX (7.523). IDXX has higher annual earnings (EBITDA): 1.16B vs. XRAY (-811M). XRAY has more cash in the bank: 295M vs. IDXX (133M). IDXX has less debt than XRAY: IDXX (1.15B) vs XRAY (2.25B). XRAY has higher revenues than IDXX: XRAY (3.94B) vs IDXX (3.51B).
IDXXXRAYIDXX / XRAY
Capitalization36.4B7.23B503%
EBITDA1.16B-811M-143%
Gain YTD7.5238.06893%
P/E Ratio46.5119.23242%
Revenue3.51B3.94B89%
Total Cash133M295M45%
Total Debt1.15B2.25B51%
FUNDAMENTALS RATINGS
IDXX vs XRAY: Fundamental Ratings
IDXX
XRAY
OUTLOOK RATING
1..100
6156
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
47100
SMR RATING
1..100
1395
PRICE GROWTH RATING
1..100
5559
P/E GROWTH RATING
1..100
4484
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for IDXX (87). This means that XRAY’s stock grew significantly faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (47) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that IDXX’s stock grew somewhat faster than XRAY’s over the last 12 months.

IDXX's SMR Rating (13) in the Medical Specialties industry is significantly better than the same rating for XRAY (95). This means that IDXX’s stock grew significantly faster than XRAY’s over the last 12 months.

IDXX's Price Growth Rating (55) in the Medical Specialties industry is in the same range as XRAY (59). This means that IDXX’s stock grew similarly to XRAY’s over the last 12 months.

IDXX's P/E Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for XRAY (84). This means that IDXX’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXXRAY
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 25 days ago
68%
Bullish Trend 11 days ago
62%
Declines
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
47%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRX0.960.04
+4.33%
Mangoceuticals
TCBI59.78-0.80
-1.32%
Texas Capital Bancshares
ULTA404.25-7.06
-1.72%
Ulta Beauty
ZOM0.17N/A
-2.41%
Zomedica Corp
GNLX27.60-1.17
-4.07%
Genelux Corp

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been closely correlated with RVTY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDXX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
-3.67%
RVTY - IDXX
69%
Closely correlated
-1.74%
COO - IDXX
67%
Closely correlated
-2.44%
IQV - IDXX
63%
Loosely correlated
-3.04%
HOLX - IDXX
62%
Loosely correlated
-1.93%
ISRG - IDXX
60%
Loosely correlated
-2.61%
More